FierceBiotech 14 mai 2026 Biopharma leaders rally behind Pazdur for FDA commissioner pick. But does he want the role?
FierceBiotech 14 mai 2026 Aptose, facing cash crunch, exits blood cancer pact after Hanmi buyout blocks development
FierceBiotech 13 mai 2026 Icon opens early-phase research unit in San Antonio, plus satellite clinics to grow trial capabilities
FierceBiotech 13 mai 2026 Humacyte cuts spending, staff as it seeks to boost sluggish sales for its off-the-shelf artery implant
FierceBiotech 13 mai 2026 With $1B Novo deal and diabetes ambitions undimmed, Lexicon is in ‘good shape to go crazy’
FierceBiotech 13 mai 2026 Valneva to lay off up to 15% of workforce in face of ‘adverse trend’ in travel vaccines
FierceBiotech 13 mai 2026 Medtronic to shutter Santa Rosa plant as it restructures cardio vascular unit
FierceBiotech 12 mai 2026 Kyverna begins rolling submission for autoimmune CAR-T as FDA requests more natural history analysis
FierceBiotech 12 mai 2026 Alphabet's AI biotech Isomorphic Labs bags $2.1B series B to fuel next-gen drug design model
FierceBiotech 12 mai 2026 Boehringer furthers inflammatory expansion with €407M biobucks bet on Immunitas asset